Follow us on:

Zotefoams plc Expanded Nike relationship, exciting trial for Rezorce and record H1 profits (VIDEO)

Zotefoams plc (LON:ZTF) CEO David Stirling joins DirectorsTalk to discuss interim results for the six months ended 30 June 2023.

David talks us through the financial highlights, explains how the main divisions have performed, expands on the exclusive agreement with Nike that has been extended to 31 December 2029, more about joint the development agreement for ReZorce and how David sees the outlook for the company.

Zotefoams plc (LON: ZTF) is a world leader in cellular material technology that is well positioned with well invested, differentiated assets and a clear strategy for organic growth.

You might also enjoy reading Zotefoams CEO Reveals Record-Breaking Results and Innovations for 2024 (VIDEO)

Find more news, interviews, share price & company profile here for:

Share this interview

Other Interviews

More News

Zotefoams plc Strong portfolio of products delivers another record year March 19, 2019
Zotefoams Plc Record third quarter sales performance November 1, 2018
INTERVIEW: Zotefoams Record Group Revenue of £37.89m August 8, 2018
Zotefoams plc Continuing strong organic sales growth August 7, 2018
INTERVIEW: Zotefoams Plc Strong global growth drivers adds to positive outlook March 13, 2018
Zotefoams plc Reports continued strong trading January 10, 2018
Zotefoams PLC Directorate Change December 21, 2017
Zotefoams PLC Increased demand – £12 million investment for Croydon facility December 14, 2017
Zotefoams PLC Strategic Partnership with Nike December 13, 2017
Zotefoams PLC Continued strong trading through Q3 November 1, 2017

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.